Investment Summary |
|
|---|---|
| Date | 2021-07-02 |
| Target | CVRx |
| Sector | Medical Products |
| Sellers(s) | SightLine Partners |
| Deal Type | IPO |
SEARCH BY
| Category | Growth Capital Firm |
|---|---|
| Founded | 2004 |
| Size | Small |
| Type | Sector Focused |
SightLine Partners is a private investment firm that targets early to late stage investments in growing healthcare and medical technology companies. Depending on the maturity of the company, Sightline will invest between $2 and $8 million per transaction. SightLine prefers US based opportunities. SightLine Partners LLC was formed in 2004 and is based in Minneapolis, Minnesota.
| DEAL STATS | # |
|---|---|
| Overall | 16 of 16 |
| Sector: Medical Products M&A | 15 of 15 |
| Type: IPO M&A Deals | 2 of 2 |
| State: Minnesota M&A | 5 of 5 |
| Country: United States M&A | 16 of 16 |
| Year: 2021 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-03-03 |
Atritech
Plymouth, Minnesota, United States Atritech, Inc. is a clinical stage medical device company and developed the Watchman (a device to treat atrial fibrillation). |
Sell | $375M |
